Health Effects of Silver-Mercury Dental Fillings

Sponsor
University of Washington (Other)
Overall Status
Completed
CT.gov ID
NCT00066118
Collaborator
National Institute of Dental and Craniofacial Research (NIDCR) (NIH)
507
1
174
2.9

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether there are detectable health effects of low-level mercury exposure (from normal exposure to mercury-containing dental fillings) in the known target organs/systems affected by elemental mercury exposure.

Condition or Disease Intervention/Treatment Phase
  • Device: Dental amalgam restorations
Phase 3

Detailed Description

The Casa Pia Study of the Health Effects of Dental Amalgam in Children is a randomized, prospective clinical trial with the overall goal of determining if there are detectable health effects due to exposure from mercury-containing dental amalgam fillings. Children, thought to be the population most susceptible to any possible health effects, were randomly assigned to one of two treatment groups (total n=507). Subjects were originally enrolled at ages between 8-10 years of age. To participate, subjects must have: Dental caries in at least one posterior tooth; no prior exposure to dental amalgam; a blood lead of <15ug/L; a urinary mercury level of <10ug/L; an IQ as measured by the CTONI of >67; and no prior or existing serious medical or neurologic condition. One group received only dental filling materials other than those containing mercury (plastic and ceramic composites), while the other group received mercury amalgam fillings where appropriate (in large restorations in back teeth), but the alternative materials everywhere else. Both treatment regimens are standard-of-care throughout the world. Subjects receive ongoing dental care via the study clinics, and continue to receive dental fillings as needed based on group assignment. The target organs of mercury exposure are renal and neurological. Baseline and annual repeated measures are taken on all subjects for renal function, nerve conduction velocity and a large battery of neurobehavioral tests. Follow-up is planned for a period of 7 years

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single
Primary Purpose:
Treatment
Official Title:
The Casa Pia Study of the Health Effects of Dental Amalgam in Children.
Study Start Date :
Aug 1, 1996
Actual Primary Completion Date :
Jul 1, 2005
Actual Study Completion Date :
Feb 1, 2011

Outcome Measures

Primary Outcome Measures

  1. Memory []

  2. Rey Auditory Verbal Learning, []

  3. Finger Windows, []

  4. Visual Learning []

  5. Visual Motor Functions []

  6. Drawing, MatchingP []

  7. Pegboard sub-tests from the Wide Range Assessment of Visual Motor Abilities. []

  8. Attention/Concentration []

  9. Coding []

  10. Symbol Search []

  11. Digit Span []

  12. Standard Reaction Time []

  13. Stroop []

  14. Trails A and B. []

  15. Neurological: Nerve Conduction Velocity []

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
  • Age 8-10 years of age

  • Dental caries in at least one posterior tooth.

  • No prior exposure to dental amalgam

  • Blood lead of <15ug/L

  • Urinary mercury level of <10ug/L

  • IQ as measured by the CTONI of >67

  • No prior or existing serious medical or neurologic condition

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Washington, School of Dentistry Seattle Washington United States 98195

Sponsors and Collaborators

  • University of Washington
  • National Institute of Dental and Craniofacial Research (NIDCR)

Investigators

  • Principal Investigator: Timothy DeRouen, University of Washington
  • Study Chair: Michael Martin, University of Washington

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Timothy DeRouen, Professor Emeritus of Oral Health Sciences, School of Dentistry, University of Washington
ClinicalTrials.gov Identifier:
NCT00066118
Other Study ID Numbers:
  • 10085
  • U01DE011894
  • 95-0401-A 13
  • NIDCR-11894
  • NCT00000365
First Posted:
Aug 5, 2003
Last Update Posted:
Jun 4, 2018
Last Verified:
May 1, 2018
Keywords provided by Timothy DeRouen, Professor Emeritus of Oral Health Sciences, School of Dentistry, University of Washington
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 4, 2018